
### [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557)
**Label:** Chilblain lupus

**Subclasses:** [MONDO:0013739](http://purl.obolibrary.org/obo/MONDO_0013739) (Chilblain lupus 2), [MONDO:0012500](http://purl.obolibrary.org/obo/MONDO_0012500) (Chilblain lupus 1), 

**Corr. equiv. classes:** [OMIM:614415](http://purl.obolibrary.org/obo/OMIM_614415), [OMIM:610448](http://purl.obolibrary.org/obo/OMIM_610448), 

**Class expressions from DL-Learner:**

- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) and [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) and [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 75.00%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) and [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 75.00%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) and [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%
- [HP:0003493](http://purl.obolibrary.org/obo/HP_0003493) (Antinuclear antibody positivity) and [HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0200042](http://purl.obolibrary.org/obo/HP_0200042) (Skin ulcer) 75.00%


